Cargando…

Use of Disease-Modifying Treatments in Patients With Sickle Cell Disease

IMPORTANCE: Despite hydroxyurea being an established treatment for sickle cell disease (SCD), it remains underused. The recent approval of the disease-modifying treatments (DMTs) l-glutamine, crizanlizumab, and voxelotor underscores the need to understand the uptake of DMTs in the current treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Newman, Terri Victoria, Yang, Jingye, Suh, Kangho, Jonassaint, Charles R., Kane-Gill, Sandra L., Novelli, Enrico M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665975/ https://www.ncbi.nlm.nih.gov/pubmed/37991760 http://dx.doi.org/10.1001/jamanetworkopen.2023.44546

Ejemplares similares

Use of Mobile Health Apps and Wearable Technology to Assess Changes and Predict Pain During Treatment of Acute Pain in Sickle Cell Disease: Feasibility Study
por: Johnson, Amanda, et al.
Publicado: (2019)

Tailoring a Digital Mental Health Program for Patients With Sickle Cell Disease: Qualitative Study
por: Nikolajski, Cara, et al.
Publicado: (2023)

Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
por: Lubeck, Deborah, et al.
Publicado: (2019)

Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method
por: Gray, Matthew P., et al.
Publicado: (2022)

Left Ventricular Rotational Mechanics in Tanzanian Children with Sickle Cell Disease
por: Di Maria, Michael V., et al.
Publicado: (2015)

Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care
por: Kanter, Julie, et al.
Publicado: (2020)

Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease
por: Harris, Kelly M., et al.
Publicado: (2023)

Screening for Cognitive Dysfunction Using the Rowland Universal Dementia Assessment Scale in Adults With Sickle Cell Disease
por: Forté, Stéphanie, et al.
Publicado: (2021)

Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
por: Afrin, Lawrence B.
Publicado: (2014)

Emerging disease-modifying therapies for sickle cell disease
por: Carden, Marcus A., et al.
Publicado: (2019)

Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals
por: Hyacinth, Hyacinth I., et al.
Publicado: (2021)

Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease
por: Novelli, Enrico M., et al.
Publicado: (2014)

Regional differences in awareness and attitudes regarding genetic testing for disease risk and ancestry
por: Jonassaint, Charles R., et al.
Publicado: (2010)

Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease
por: Doss, Jennifer F., et al.
Publicado: (2016)

Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis
por: Kirkham, Justin K., et al.
Publicado: (2023)

Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial
por: Abrams, Donald I., et al.
Publicado: (2020)

Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018
por: Early, Macy L., et al.
Publicado: (2023)

The Effect of an Adapted Digital Mental Health Intervention for Sickle Cell Disease on Engagement: A Pilot Randomized Controlled Trial
por: Parchuri, Ektha, et al.
Publicado: (2023)

Analysis of hippocampal subfields in sickle cell disease using ultrahigh field MRI
por: Santini, Tales, et al.
Publicado: (2021)

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial
por: Stevens, Kara N., et al.
Publicado: (2022)

Association between trauma triage and time-to-vaso-occlusive events in patients with sickle cell disease after traumatic injury: a retrospective study
por: Parchuri, Ektha, et al.
Publicado: (2023)

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study
por: Sinha, Cynthia B., et al.
Publicado: (2019)

Risk of Bacteremia in Febrile Children and Young Adults With Sickle Cell Disease in a Multicenter Emergency Department Cohort
por: Rineer, Stephen, et al.
Publicado: (2023)

Comparisons of Severe Maternal Morbidity and Other Adverse Pregnancy Outcomes in Pregnant People With Sickle Cell Disease vs Anemia
por: Early, Macy L., et al.
Publicado: (2023)

Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France
por: Assad, Zein, et al.
Publicado: (2022)

Endothelial superoxide dismutase 2 is decreased in sickle cell disease and regulates fibronectin processing
por: Dosunmu-Ogunbi, Atinuke, et al.
Publicado: (2022)

P1433: POSITRON EMISSION TOMOGRAPHY IMAGING OF VLA-4 AS A NEW BIOMARKER OF VASO-OCCLUSION IN SICKLE CELL DISEASE
por: Zhu, Qin, et al.
Publicado: (2023)

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
por: Luo, Jiao, et al.
Publicado: (2023)

Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease: A Qualitative Study
por: Bakshi, Nitya, et al.
Publicado: (2020)

Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010–2019
por: Zhu, Wen, et al.
Publicado: (2022)

Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002)

Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease
por: Yu, Tzy-Chyi, et al.
Publicado: (2015)

Evaluation of Stillbirth Among Pregnant People With Sickle Cell Trait
por: Canelón, Silvia P., et al.
Publicado: (2021)

Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease
por: Bakshi, Nitya, et al.
Publicado: (2017)

Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires
por: Saleh, Marwah Adly, et al.
Publicado: (2019)

Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study
por: Badawy, Sherif M, et al.
Publicado: (2021)

Using Drosophila to identify naturally occurring genetic modifiers of amyloid beta 42- and tau-induced toxicity
por: Yang, Ming, et al.
Publicado: (2023)

The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology
por: Green, Nancy S., et al.
Publicado: (2022)

Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines
por: Reeves, Sarah L., et al.
Publicado: (2023)

S125: THE ROLE OF THE MICROBIOME AS A SICKLE CELL DISEASE MODIFIER: AN EXPERT REVIEW
por: Oosterwyk, C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9fd023sqtv64nv7fid5ttrgac8